Nyxoah Past Earnings Performance

Past criteria checks 0/6

Nyxoah's earnings have been declining at an average annual rate of -37.5%, while the Medical Equipment industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 62.1% per year.

Key information

-37.5%

Earnings growth rate

-23.4%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate62.1%
Return on equity-50.6%
Net Margin-1,042.5%
Next Earnings Update13 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Nyxoah makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:5YI Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 245-532530
30 Jun 245-442229
31 Mar 245-432228
31 Dec 234-432227
30 Sep 234-462224
30 Jun 233-442222
31 Mar 233-362018
31 Dec 223-311916
30 Sep 222-241715
30 Jun 222-271714
31 Mar 221-291714
31 Dec 211-281512
30 Sep 211-251310
30 Jun 210-21128
31 Mar 210-1695
31 Dec 200-1292
30 Sep 200-873
30 Jun 200-562
31 Mar 200-452
31 Dec 190-442
31 Dec 180-934

Quality Earnings: 5YI is currently unprofitable.

Growing Profit Margin: 5YI is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 5YI is unprofitable, and losses have increased over the past 5 years at a rate of 37.5% per year.

Accelerating Growth: Unable to compare 5YI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 5YI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: 5YI has a negative Return on Equity (-50.6%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 23:39
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nyxoah S.A. is covered by 10 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David RescottBaird
Michael PolarkBaird
Ross OsbornCantor Fitzgerald & Co.